<DOC>
	<DOCNO>NCT01231633</DOCNO>
	<brief_summary>The purpose study compare visual improvement total number intraocular injection eye macular edema follow central retinal vein occlusion ( CRVO ) initial treatment Ozurdex ( dexamethasone implant ) Avastin ( bevacizumab ) .</brief_summary>
	<brief_title>Comparison Initial Ozurdex ( Dexamethasone Implant ) Avastin ( Bevacizumab ) Treatment Macular Edema Caused Central Retinal Vein Occlusion ( CRVO )</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Presence central retinal vein occlusion ( CRVO ) Age 18 year old ETDRS Visual acuity 3 72 letter approximate Snellen equivalent 20/40 20/800 OCT Central foveal thickness &gt; 250 micron Negative pregnancy test woman childbearing potential Ability provide write informed consent Capable comply study protocol History glaucoma study eye intraocular pressure &gt; 21mmHg one topical medication . Combination drug consider one medication History steroidrelated glaucoma ( steroid response ) Previous intraocular injection steroid medication within 90 day Avastin ( bevacizumab ) Lucentis ( ranibizumab ) within 60 day Evidence significant retinal ischemia fluorescein angiography opinion treat physician Previous intraocular surgery ( e.g . Cataract Surgery ) 60 day Concurrent ocular disease would limit visual acuity opinion treat physician Dense cataract preclude clinical examination retinal imaging retina History allergy dexamethasone , bevacizumab , betadine Ocular systemic condition may pose threat health subject opinion treat physician Unwilling unable follow comply study relate procedure Current participation another clinical medical investigation trial receive investigational drug within 12 week prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Macular Edema</keyword>
	<keyword>Central Retinal Vein Occlusion</keyword>
</DOC>